29-Oct-2015 | S | Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 29, 2015, has approved the sub-division (stock split) of one equity share of the Company having a face value of Rs. 10/- each into five equity shares of face value of Rs. 2/- each. The sub-division of shares will be subject to approval by the shareholders of the Company and any other statutory and regulatory approvals.
SUB. :- Sub Division of equity shares of Sequent Scientific Limited (Scrip Code 512529)
Trading Members of the Exchange are hereby informed that, Sequent Scientific Ltd. has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Sequent Scientific Ltd.
(512529)
RECORD DATE
26/02/2016
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into FIVE equity shares of Rs.2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
25/02/2016 DR-227/2015- 2016
Note:-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 2/- paid up w.e.f. 25/02/2016.
ii. ISIN No. INE807F01019 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 25/02/2016.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 12.02.2016) | 26-Feb-2016 | |
30-Jun-2021 | D | The Board of Directors at their meeting held today have recommended a final dividend of Rs. 0.50 (25%)
per equity share for the financial year ended March 31, 2021. | 08-Sep-2021 | |
14-May-2019 | D | Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 14, 2019, inter alia, has recommended dividend at the rate of 10% i.e. INR 0.20 paise per share for the financial year ended March 31, 2019. | 21-Aug-2019 | |
09-Nov-2017 | D | The Board had at its Meeting held today
a) Approved an Interim Dividend of INR 20 paise per equity share having face value of INR 2 each for Financial Year 2017-18.
b) Have fixed November 21, 2017 as the 'Record Date' for the purpose of payment of said interim dividend to shareholders.
The aforesaid interim dividend will be paid /despatched before December 4, 2017 to the shareholders.
You are requested to take the same on record.
Sequent Scientific Ltd has informed BSE that the Board of Directors in their meeting held on November 09, 2017, inter alia, has declared an interim dividend of 10% i.e. Rs. 0.20 per equity share of Rs. 2/- each. | 20-Nov-2017 | |
27-May-2011 | D | Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2011, inter alia, has recommended dividend at 15% viz., Rs. 1.50 per share for the year ended March 31, 2011. | 16-Sep-2011 | |
29-May-2010 | D | Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2010, inter alia, has recommended a dividend of Rs. 2 (20%) per equity share of Rs. 10/- for the year. | 23-Sep-2010 | |
23-Jun-2009 | D | PI Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 22, 2009, inter alia, has recommended a dividend of 10% to the Equity Shareholders for the financial year 2008-09. | 02-Sep-2009 | |
27-Jun-2008 | D | PI Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 27, 2008, inter alia, has recommended a dividend of 10% to the Equity shareholders for the financial year 2007-08. | 11-Sep-2008 | |
21-Jun-2007 | D | PI Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 20, 2007, inter alia, has recommend a Dividend of Rs 1/- per Equity Shares (10%) subject to approval of the Shareholders | 13-Sep-2007 | |
04-Apr-2024 | BC | Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Intimation of resignation of Mr. Sharat Pandurang Narasapur Joint Managing Director. | 30-Apr-2024 | |
16-Apr-2024 | BC | Appointment Of Director | 17-Apr-2024 | |
05-Feb-2024 | BC | Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), we would | 07-Mar-2024 | |
13-Feb-2024 | BC | Appointment of Company Secretary and Compliance Officer | 16-Feb-2024 | |
06-Dec-2023 | BC | We wish to inform you that Mr. Krunal Shah has resigned from the position of Company Secretary & Compliance Officer due to personal reasons. He will continue in his role till the close of business ho | 15-Feb-2024 | |
Announcement Date30-Jun-2021
Ex Dividend Date08-Sep-2021
Dividend(%)25
Announcement Date14-May-2019
Ex Dividend Date21-Aug-2019
Dividend(%)10
Announcement Date09-Nov-2017
Ex Dividend Date20-Nov-2017
Dividend(%)10
Announcement Date27-May-2011
Ex Dividend Date16-Sep-2011
Dividend(%)15
Announcement Date29-May-2010
Ex Dividend Date23-Sep-2010
Dividend(%)20
Announcement Date23-Jun-2009
Ex Dividend Date02-Sep-2009
Dividend(%)10
Announcement Date27-Jun-2008
Ex Dividend Date11-Sep-2008
Dividend(%)10
Announcement Date21-Jun-2007
Ex Dividend Date13-Sep-2007
Dividend(%)10
No Bonus has been declared by SEQUENT
Record Date26-Feb-2016
Split Date25-Feb-2016
Face Value (Before/After)10/2
RightsNo Rights has been declared by SEQUENT
Book Closure
30-Apr-2024 | - | Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Intimation of resignation of Mr. Sharat Pandurang Narasapur Joint Managing Director. |
17-Apr-2024 | - | Appointment Of Director |
07-Mar-2024 | 01 Jan'1900 | Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), we would |
16-Feb-2024 | - | Appointment of Company Secretary and Compliance Officer |
15-Feb-2024 | - | We wish to inform you that Mr. Krunal Shah has resigned from the position of Company Secretary & Compliance Officer due to personal reasons. He will continue in his role till the close of business ho |